Moremen, Kelley W. http://orcid.org/0000-0003-1768-582X
Haltiwanger, Robert S. http://orcid.org/0000-0001-7439-9577
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM061126)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD090156, HD096030)
Article History
Received: 22 February 2019
Accepted: 17 July 2019
First Online: 19 August 2019
Competing interests
: K.W.M. acknowledges ownership interest and roles as President and CEO of Glyco Expression Technologies, Inc., a biotechnology spinout commercializing recombinant glycosyltransferases, and may conceivably profit from the results described herein.